Brief: Auris Medical Provides Update On Ongoing Clinical Trials With Intranasal Betahistine

Altamira Therapeutics

05/03/2020 14:12

March 5 (Reuters) - Auris Medical Holding Ltd  EARS.O :
    * AURIS MEDICAL PROVIDES UPDATE ON ONGOING CLINICAL TRIALS
WITH
INTRANASAL BETAHISTINE
    * AURIS MEDICAL HOLDING LTD - PHASE 2 TRIAL WITH AM-125 IN
TREATMENT OF ACUTE PERIPHERAL VERTIGO PROGRESSING TOWARDS
INTERIM ANALYSIS IN Q2 2020
    * AURIS MEDICAL HOLDING LTD - FOR PHASE 1B TRIAL WITH
AM-201, CO
EXPECTS TO REPORT TOP-LINE DATA IN EARLY MAY 2020, IN ACCORDANCE
WITH PREVIOUS GUIDANCE

Source text for Eikon:  ID:nGNXcdxrGg 
Further company coverage:  EARS.O 

 ((Reuters.Briefs@thomsonreuters.com;))